Li-Cycle Holdings ( NYSE:LICY ) Full Year 2022 Results Key Financial Results Revenue: US$13.4m (up 82% from FY 2021...
Legacy Ridge Capital Management, LLC recently published its “Legacy Ridge Capital Partners Equity Fund I” fourth quarter 2022 investor letter, which can be downloaded here. In 2022, the fund returned 12.5% gross and 10.3% net of performance fees compared to a -18.1% return for the S&P 500 Index. In addition, please check the fund’s top five […]
On any list of biotech plays that might multiply in value in a relatively short period, Cassava Sciences (NASDAQ: SAVA) is likely to be near the top of the list. It's exploring whether its drug called simufilam is safe and effective to treat early-stage Alzheimer's disease, though its clinical trials have (so far) shed little light on the issue. The biggest reason to sell Cassava stock: After an open-label phase 2 clinical trial of simufilam, the market reacted quite negatively to the release of new data that management spun as being positive.
When Cathie Wood speaks, people listen. The chief executive of Ark Investment Management has had a far-from-perfect record when it comes to her investment choices -- not to mention not exactly flattering feedback from CNBC's Jim Cramer. When asked what stock Wood would choose she won a million dollar lottery and was forced to choose a stock for ten years, Wood's pick was just as disruptive as her reputation.
For the third day in a row, Tesla (NASDAQ: TSLA) stock is riding higher -- up 4.3% as of 10:10 a.m. ET. The Federal Reserve's decision to raise interest rates only 25 basis points yesterday is probably part of the reason for that -- indeed, growth stocks in general seem happy to run today, with the entire Nasdaq up nearly 2%. Tesla's plan to cut the prices of its electric cars, you see -- not just in the U.S., but in China as well -- is having its intended effect of stoking consumer demand.
Shares of Coinbase (NASDAQ: COIN) have gotten crushed since hitting public markets, but the business is in better shape than you might think. There's billions of dollars in cash on the balance sheet, and there are growing revenue sources from USDC and Ethereum (CRYPTO: ETH) staking.
The Nasdaq Composite dipped into a bear market last year, and the tech-heavy index is still 28% off its high. Investors often overreact to good and bad news, so stocks tend to rise too high during bull markets and fall too far during bear markets. Warren Buffett hinted at that quirk of human nature when he said, "Be fearful when others are greedy, and be greedy when others are fearful."
A short squeeze occurs when short-sellers rush to cover their positions on a stock. The sudden rush of buying can quickly push a stock price higher. After a tough market year in 2022, some stocks have built up large short-seller followings, potentially priming the pump for a new wave of short squeezes.
Despite a dismal performance in 2022, shares of all-digital bank SoFi Technologies (NASDAQ: SOFI) climbed 50.3% in January. There are lots of reasons for the run-up, not least of which were a better-than-expected performance during the fourth quarter of 2022 and an improved outlook. Will the big gains SoFi made in January fizzle out in February, or is the stock at the beginning of a much longer bull run?
Air products' (APD) Q1 performance was driven by higher prices and volumes across its segments amid headwinds from unfavorable currency translations.
Yahoo Finance Live’s Julie Hyman breaks down oil earnings.
Dividend investors should consider loading up on these stocks as this could be a good year for both of their businesses.
Change doesn't have to be bad.
Shares of connected-TV platform company Roku (NASDAQ: ROKU) jumped 41.3% in January, according to data provided by S&P Global Market Intelligence. Roku's gains seem to be based on some fundamental improvements to the business, which is good. Roku kicked off the new year by launching its own line of smart TVs.
Archer-Daniels-Midland, Agilent Technologies, Republic Services, Deere and Cardinal Health have been highlighted in this Screen of The Week article.
Did you know that if a company were to increase its dividends by 5% per year, it would take 14 years for its payouts to double? A couple of stocks with the most aggressive dividend growth records you can invest in today are UnitedHealth Group (NYSE: UNH) and Broadcom (NASDAQ: AVGO). Health insurance giant UnitedHealth Group may not strike income investors as an ideal dividend stock to buy, as it yields just under 1.4%, which is below the S&P 500's current average yield of 1.7%.
(Bloomberg) -- Most Read from BloombergMerck Covid Drug Linked to New Virus Mutations, Study SaysAdani Crisis Deepens as Stock Rout Hits $108 BillionPorsche Blunder Puts $148,000 Sportscar on Sale for Just $18,000Plenty of Americans Are Drinking Bleach, Still for Sale on AmazonHong Kong to Give Away 500,000 Air Tickets to Revive TourismOPEC’s crude output edged lower last month as the group pressed on with an accord to keep global markets in balance.The Organization of Petroleum Exporting Countr
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $317.27, marking a -1.8% move from the previous day.
These high-octane income stocks, with yields ranging from 4.3% to 15.4%, have been bought hand over fist by billionaire investors.
This year has started with a ‘bang’ for stocks, a January rally that saw the S&P gain 6% and the NASDAQ jump 11%, a welcome change in mood from the volatile declines we saw in 2022. Even so, there is still a degree of caution. Last year’s headwinds are still with us, in the form of stubbornly high inflation and interest rates at decadal highs. For the average investor, charting a course through these waters is a daunting task. It is in time like this that some expert advice might provide a clear